BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah MA, Kurtz RC. Upper gastrointestinal cancer predisposition syndromes. Hematol Oncol Clin North Am 2010;24:815-35. [PMID: 20816576 DOI: 10.1016/j.hoc.2010.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Wang JB, Yang H, Fan JH, Qiao YL, Taylor PR. Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort. Cancer Epidemiol 2020;65:101683. [PMID: 32045872 DOI: 10.1016/j.canep.2020.101683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Verdaguer H, Saurí T, Macarulla T. Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment. J Gastrointest Oncol 2017;8:405-17. [PMID: 28736628 DOI: 10.21037/jgo.2016.11.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
3 Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Sachlova M, Svoboda M, Slaby O. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus. Tumor Biol 2016;37:8007-18. [DOI: 10.1007/s13277-015-4656-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
4 Golan T, Kanji ZS, Epelbaum R, Devaud N, Dagan E, Holter S, Aderka D, Paluch-Shimon S, Kaufman B, Gershoni-Baruch R, Hedley D, Moore MJ, Friedman E, Gallinger S. Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers. Br J Cancer 2014;111:1132-8. [PMID: 25072261 DOI: 10.1038/bjc.2014.418] [Cited by in Crossref: 202] [Cited by in F6Publishing: 228] [Article Influence: 25.3] [Reference Citation Analysis]
5 Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11:145-156. [PMID: 24492836 DOI: 10.1038/nrclinonc.2014.5] [Cited by in Crossref: 621] [Cited by in F6Publishing: 664] [Article Influence: 77.6] [Reference Citation Analysis]
6 Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One. 2013;8:e64463. [PMID: 23724052 DOI: 10.1371/journal.pone.0064463] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]